Astera Labs (NASDAQ:ALAB) General Counsel Philip Mazzara Sells 6,801 Shares of Stock

Key Points

• Astera Labs’ General Counsel Philip Mazzara sold 6,801 shares for approximately $2.32 million at an average price of $340.50. The sale was made to cover tax withholding tied to vested equity awards, leaving him with 96,542 shares.
• Astera Labs reported quarterly earnings of $0.80 per share, exceeding the $0.69 consensus estimate, while revenue rose 104.5% year over year to $392.4 million.
• The stock recently traded at $289.02, down $14.42, while analysts maintain a “Moderate Buy” consensus and an average price target of $333. Institutional investors own 60.47% of the company.

Astera Labs, Inc. (NASDAQ:ALAB - Get Free Report) General Counsel Philip Mazzara sold 6,801 shares of Astera Labs stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $340.50, for a total value of $2,315,740.50. Following the completion of the transaction, the general counsel owned 96,542 shares in the company, valued at approximately $32,872,551. This represents a 6.58% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Philip Mazzara also recently made the following trade(s):

• On Thursday, May 21st, Philip Mazzara sold 796 shares of Astera Labs stock. The shares were sold at an average price of $291.03, for a total value of $231,659.88.

Astera Labs Stock Performance

ALAB traded down $14.42 on Wednesday, hitting $289.02. 4,217,656 shares of the company were exchanged, compared to its average volume of 5,487,682. The firm has a fifty day simple moving average of $356.72 and a two-hundred day simple moving average of $242.75. The stock has a market capitalization of $50.14 billion, a PE ratio of 143.08 and a beta of 3.84. Astera Labs, Inc. has a 12 month low of $97.89 and a 12 month high of $499.48.

Astera Labs (NASDAQ:ALAB - Get Free Report) last announced its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 earnings per share for the quarter, beating the consensus estimate of $0.69 by $0.11. The firm had revenue of $392.40 million during the quarter, compared to the consensus estimate of $360.85 million. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The business's revenue was up 104.5% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.44 earnings per share. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, equities analysts expect that Astera Labs, Inc. will post 2.7 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on the stock. Jefferies Financial Group raised their price target on shares of Astera Labs from $270.00 to $450.00 and gave the stock a "buy" rating in a report on Wednesday, August 5th. UBS Group reiterated a "neutral" rating and issued a $425.00 price objective on shares of Astera Labs in a report on Wednesday, August 5th. Evercore restated an "outperform" rating and set a $297.00 target price on shares of Astera Labs in a report on Tuesday, May 19th. TD Cowen cut their price target on shares of Astera Labs from $425.00 to $375.00 and set a "hold" rating on the stock in a report on Wednesday, August 5th. Finally, Barclays lifted their price target on shares of Astera Labs from $200.00 to $325.00 and gave the company an "equal weight" rating in a report on Monday, July 20th. One research analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and eight have assigned a Hold rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $333.00.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in the company. Royal Bank of Canada grew its stake in Astera Labs by 167.3% in the first quarter. Royal Bank of Canada now owns 152,453 shares of the company's stock worth $9,097,000 after purchasing an additional 95,409 shares during the period. AQR Capital Management LLC increased its stake in shares of Astera Labs by 213.4% in the 1st quarter. AQR Capital Management LLC now owns 11,391 shares of the company's stock worth $680,000 after acquiring an additional 7,756 shares in the last quarter. Empowered Funds LLC increased its stake in shares of Astera Labs by 917.3% in the 1st quarter. Empowered Funds LLC now owns 4,639 shares of the company's stock worth $277,000 after acquiring an additional 4,183 shares in the last quarter. First Trust Advisors LP lifted its position in Astera Labs by 102.0% during the 2nd quarter. First Trust Advisors LP now owns 112,766 shares of the company's stock valued at $10,196,000 after acquiring an additional 56,952 shares during the period. Finally, Brown Advisory Inc. boosted its stake in Astera Labs by 54.9% during the second quarter. Brown Advisory Inc. now owns 5,581 shares of the company's stock worth $505,000 after acquiring an additional 1,977 shares in the last quarter. Hedge funds and other institutional investors own 60.47% of the company's stock.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company's product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source